Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Operating Margin

Related VIVO
Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROI
Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS
Related TRIB
Worst Performing Industries For November 3, 2014
Trinity Biotech Announces Quarter 3 Financial Results And Temporary Suspension Of Meritas Troponin Trials

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of operating margin.

The trailing-twelve-month operating margin at SurModics (NASDAQ: SRDX) is 32.12%. SurModics had $28.43 million in total cash for the latest quarter.

The trailing-twelve-month operating margin at Meridian Bioscience (NASDAQ: VIVO) is 30.48%. Meridian Bioscience's ROE for the same period is 25.63%.

The trailing-twelve-month operating margin at Trinity Biotech plc (NASDAQ: TRIB) is 19.54%. Trinity Biotech's revenue for the same period is $86.08 million.

The trailing-twelve-month operating margin at Quidel (NASDAQ: QDEL) is 10.92%. Quidel's PEG ratio is 5.12.

Posted-In: Diagnostic Substances Industry Operating Margin small-capTrading Ideas

 

Related Articles (QDEL + SRDX)

Around the Web, We're Loving...

Get Benzinga's Newsletters